Siemens Healthineers and Novo team up on fatty liver disease awareness, testing September 22, 2026Posted inMedical Technology Siemens Healthineers is joining forces with Novo to help boost awareness and diagnosis of fatty liver disease. Post navigation Previous Post Cordis’ sirolimus drug-coated balloon earns FDA approval as a breakthrough deviceNext PostOtsuka heads to FDA as Ionis-partnered ALS drug hits primary phase 3 endpoint
